WallStreetZenWallStreetZen

NYSE: CNMD
Conmed Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Conmed earnings were $110.2M for the trailing 12 months ending Jun 30, 2025, with 10.9% growth year over year. The latest CNMD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $21.4M, up 254.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNMD reported annual earnings of $132.4M, with 105.4% growth. The next CNMD earnings date is Oct 22, 2025.

CNMD past earnings growth

How has CNMD's earnings growth performed historically?

Company
10.9%
Industry
85.03%
Market
30.17%
CNMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CNMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CNMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CNMD earnings history

Current Revenue
$1.3B
Current Earnings
$110.2M
Current Profit Margin
8.3%
CNMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CNMD Return on Equity

Current Company
11.4%
Current Industry
16%
Current Market
26.6%
CNMD's Return on Equity (11.4%)... subscribe to Premium to read more.
High Return on Equity Performance

CNMD undefined

Current Company
4.8%
Current Industry
9.4%
CNMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CNMD announces earnings.

CNMD undefined

Current Company
8.45%
Current Industry
11%
CNMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CNMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CNMD$189.00M$110.20M+159.94%$3.56
UFPT$112.60M$67.10M+29.79%$8.73
AORT$39.49M-$21.40MN/A-$0.50
QDEL$195.70M-$466.40MN/A-$6.88
SSII-$13.45M-$16.64MN/A-$0.09
View Top Medical Device Stocks

CNMD earnings dates

Next earnings date
Oct 22, 2025

Conmed Earnings Reports & History FAQ

What were Conmed's earnings last quarter?

On CNMD's earnings call on Invalid Date, Conmed (NYSE: CNMD) reported Q2 2025 earnings per share (EPS) of $0.69, up 28.87% year over year. Total CNMD earnings for the quarter were $21.42 million. In the same quarter last year, Conmed's earnings per share (EPS) was $0.97.

If you're new to stock investing, here's how to buy Conmed stock.

When does Conmed report earnings?

The next CNMD earnings date is Invalid Date. Add CNMD to your watchlist to be reminded of Conmed's next earnings date.

Is Conmed profitable or losing money?

As of the last Conmed earnings report, Conmed is currently profitable. Conmed's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $110.20 million, a 11.77% increase year over year.

What was CNMD's earnings growth in the past year?

As of Conmed's earnings date in Invalid Date, Conmed's earnings has grown 10.9% year over year. This is 74.13 percentage points lower than the US Medical Devices industry earnings growth rate of 85.03%. CNMD earnings in the past year totalled $110.20 million.

What are Conmed's earnings expectations?

The current EPS estimate for Conmed's earnings report in Invalid Date is $1.05.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.